{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:54:14Z","timestamp":1788339254384,"version":"build-2803163510"},"reference-count":8,"publisher":"BMJ","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:p>A 63 year old man with a six year history of Parkinson\u2019s disease presented with signs of right heart failure following a knee replacement. Constrictive pericarditis was diagnosed and a radical pericardectomy performed. Six months later, the patient remained unwell with raised inflammatory markers. An inflammatory fibrotic reaction caused by cabergoline was diagnosed. He improved after cessation of cabergoline.<\/jats:p>","DOI":"10.1136\/hrt.2004.036236","type":"journal-article","created":{"date-parts":[[2004,7,14]],"date-time":"2004-07-14T13:20:48Z","timestamp":1089811248000},"page":"e47-e47","source":"Crossref","is-referenced-by-count":22,"title":["Constrictive pericarditis and pleuropulmonary fibrosis secondary to cabergoline treatment for Parkinson\u2019s disease"],"prefix":"10.1136","volume":"90","author":[{"given":"M","family":"Townsend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D H","family":"MacIver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2004,7,14]]},"reference":[{"key":"2025092102071232000_90.8.e47.1","unstructured":"Braunwald E , Zipes D, Libby P. Heart disease: a textbook of cardiovascular disease. 6th ed. Philadelphia: WB Saunders, 2001."},{"key":"2025092102071232000_90.8.e47.2","first-page":"3","volume":"28","year":"2002","journal-title":"Curr Probl Pharmacovigilance"},{"key":"2025092102071232000_90.8.e47.3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1183\/09031936.93.05020263","volume":"5","year":"1992","journal-title":"Eur Respir J"},{"key":"2025092102071232000_90.8.e47.4","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.1.3.555"},{"key":"2025092102071232000_90.8.e47.5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1254\/fpj.117.395","volume":"117","year":"2001","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"2025092102071232000_90.8.e47.6","doi-asserted-by":"publisher","DOI":"10.4065\/74.4.371"},{"key":"2025092102071232000_90.8.e47.7","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1034\/j.1399-3003.1999.14d40.x","volume":"14","year":"1999","journal-title":"Eur Respir J"},{"key":"2025092102071232000_90.8.e47.8","unstructured":"Medicine Control Agency. Committee on Safety of Medicines. Current Problems in Pharmacovigilance 2002;28."}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.2004.036236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T09:07:21Z","timestamp":1758445641000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.2004.036236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,14]]},"references-count":8,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2004,7,14]]},"published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1136\/hrt.2004.036236"],"URL":"https:\/\/doi.org\/10.1136\/hrt.2004.036236","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,14]]}}}